Amdocs Operating Income vs Net Income Analysis

DOX
 Stock
  

USD 88.95  1.36  1.55%   

Amdocs financial indicator trend analysis is way more than just evaluating Amdocs Limited prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Amdocs Limited is a good investment. Please check the relationship between Amdocs Operating Income and its Net Income accounts. Continue to Investing Opportunities.

Operating Income vs Net Income

Operating Income vs Net Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Amdocs Limited Operating Income account and Net Income. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Amdocs' Operating Income and Net Income is 0.93. Overlapping area represents the amount of variation of Operating Income that can explain the historical movement of Net Income in the same time period over historical financial statements of Amdocs Limited, assuming nothing else is changed. The correlation between historical values of Amdocs' Operating Income and Net Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Operating Income of Amdocs Limited are associated (or correlated) with its Net Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income has no effect on the direction of Operating Income i.e., Amdocs' Operating Income and Net Income go up and down completely randomly.

Correlation Coefficient

0.93
Relationship DirectionPositive 
Relationship StrengthVery Strong

Operating Income

Operating Income is the amount of profit realized from Amdocs Limited operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Amdocs Limited is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Operating income is a measure of financial performance before the deduction of Interest Expense; Income Tax Expense and other Non-Operating items. It is calculated as Gross Profit minus Operating Expenses.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Amdocs Limited financial statement analysis. It represents the amount of money remaining after all of Amdocs Limited operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. The portion of profit or loss for the period; net of income taxes; which is attributable to the parent after the deduction of Net Income Available to Non-controlling Interests from Consolidated Income; and before the deduction of Preferred Dividends.
Most indicators from Amdocs fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Amdocs Limited current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Continue to Investing Opportunities.Amdocs Net Cash Flow Business Acquisitions and Disposals is fairly stable at the moment as compared to the past year. Amdocs reported Net Cash Flow Business Acquisitions and Disposals of 168.24 Million in 2021. Enterprise Value over EBIT is likely to rise to 15.21 in 2022, whereas Selling General and Administrative Expense is likely to drop slightly above 557.8 M in 2022.
 2019 2020 2021 2022 (projected)
Consolidated Income497.84 M688.37 M791.63 M673.75 M
Direct Expenses2.76 B2.81 B2.53 B2.34 B

Amdocs fundamental ratios Correlations

0.150.24-0.550.44-0.80.71-0.380.06-0.220.330.550.160.310.050.030.290.79-0.66-0.79
0.15-0.29-0.66-0.15-0.550.10.090.04-0.26-0.21-0.11-0.33-0.18-0.26-0.05-0.160.150.25-0.12
0.24-0.29-0.30.96-0.30.66-0.9-0.870.740.930.930.980.80.940.860.960.7-0.6-0.49
-0.55-0.66-0.3-0.50.94-0.70.460.340.01-0.33-0.53-0.24-0.21-0.26-0.33-0.44-0.680.160.73
0.44-0.150.96-0.5-0.530.8-0.92-0.80.620.890.980.940.750.890.810.960.81-0.63-0.65
-0.8-0.55-0.30.94-0.53-0.790.480.220.1-0.37-0.6-0.23-0.28-0.2-0.25-0.43-0.80.380.81
0.710.10.66-0.70.8-0.79-0.75-0.480.110.710.820.580.450.580.50.740.87-0.58-0.79
-0.380.09-0.90.46-0.920.48-0.750.85-0.67-0.86-0.88-0.87-0.69-0.86-0.91-0.91-0.780.510.56
0.060.04-0.870.34-0.80.22-0.480.85-0.85-0.85-0.74-0.84-0.73-0.87-0.96-0.83-0.550.320.31
-0.22-0.260.740.010.620.10.11-0.67-0.850.620.560.780.720.730.860.640.26-0.28-0.08
0.33-0.210.93-0.330.89-0.370.71-0.86-0.850.620.910.840.860.810.790.860.8-0.69-0.59
0.55-0.110.93-0.530.98-0.60.82-0.88-0.740.560.910.870.830.810.740.910.88-0.73-0.75
0.16-0.330.98-0.240.94-0.230.58-0.87-0.840.780.840.870.730.960.860.950.59-0.51-0.39
0.31-0.180.8-0.210.75-0.280.45-0.69-0.730.720.860.830.730.630.690.680.71-0.76-0.56
0.05-0.260.94-0.260.89-0.20.58-0.86-0.870.730.810.810.960.630.880.970.52-0.36-0.3
0.03-0.050.86-0.330.81-0.250.5-0.91-0.960.860.790.740.860.690.880.860.54-0.32-0.32
0.29-0.160.96-0.440.96-0.430.74-0.91-0.830.640.860.910.950.680.970.860.71-0.49-0.5
0.790.150.7-0.680.81-0.80.87-0.78-0.550.260.80.880.590.710.520.540.71-0.73-0.85
-0.660.25-0.60.16-0.630.38-0.580.510.32-0.28-0.69-0.73-0.51-0.76-0.36-0.32-0.49-0.730.67
-0.79-0.12-0.490.73-0.650.81-0.790.560.31-0.08-0.59-0.75-0.39-0.56-0.3-0.32-0.5-0.850.67
Click cells to compare fundamentals

Amdocs Account Relationship Matchups

Amdocs fundamental ratios Accounts

201720182019202020212022 (projected)
Receivables971.5 M987.86 M861.03 M866.82 M780.14 M737.36 M
Accounts Payable194.74 M176.51 M110.14 M121.2 M139.38 M156.14 M
Accumulated Other Comprehensive Income18.79 M(32.73 M)(2.55 M)11.66 M13.41 M14.47 M
Total Assets5.35 B5.29 B6.34 B6.51 B7.49 B7.04 B
Current Assets1.72 B1.68 B2.07 B2.07 B1.86 B1.85 B
Assets Non Current3.63 B3.62 B4.27 B4.44 B5.11 B4.59 B
Cash and Equivalents519.22 M471.63 M983.94 M965.59 M869.03 M894.22 M
Cash and Equivalents USD519.22 M471.63 M983.94 M965.59 M869.03 M894.22 M
Deferred Revenue132.41 M118.18 M126.84 M237.37 M272.98 M233.37 M
Shareholders Equity3.45 B3.5 B3.62 B3.59 B4.13 B4.14 B
Shareholders Equity USD3.45 B3.5 B3.62 B3.59 B4.13 B4.14 B
Goodwill and Intangible Assets2.71 B2.67 B2.87 B2.88 B3.31 B3.12 B
Total Liabilities1.86 B1.75 B2.68 B2.88 B3.31 B2.86 B
Current Liabilities1.29 B1.21 B1.22 B1.3 B1.5 B1.49 B
Liabilities Non Current560.82 M542.43 M1.46 B1.57 B1.81 B1.95 B
Trade and Non Trade Payables194.74 M176.51 M110.14 M1.01 B1.16 B1.25 B
Property Plant and Equipment Net496.58 M525.31 M903.45 M931.93 M1.07 B1.16 B
Trade and Non Trade Receivables971.5 M987.86 M861.03 M866.82 M996.84 M984.27 M
Accumulated Retained Earnings Deficit4.67 B5.01 B5.34 B5.85 B6.73 B5.93 B
Tax Liabilities219.42 M224.57 M207.51 M258.49 M232.64 M240.95 M

Be your own money manager

Our tools can tell you how much better you can do entering a position in Amdocs without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Volatility Analysis Now

   

Volatility Analysis

Get historical volatility and risk analysis based on latest market data
All  Next Launch Module
Continue to Investing Opportunities. Note that the Amdocs Limited information on this page should be used as a complementary analysis to other Amdocs' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Complementary Tools for Amdocs Stock analysis

When running Amdocs Limited price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Is Amdocs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amdocs. If investors know Amdocs will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amdocs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
-0.089
Market Capitalization
10.8 B
Quarterly Revenue Growth YOY
0.088
Return On Assets
0.0605
Return On Equity
0.15
The market value of Amdocs Limited is measured differently than its book value, which is the value of Amdocs that is recorded on the company's balance sheet. Investors also form their own opinion of Amdocs' value that differs from its market value or its book value, called intrinsic value, which is Amdocs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amdocs' market value can be influenced by many factors that don't directly affect Amdocs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amdocs' value and its price as these two are different measures arrived at by different means. Investors typically determine Amdocs value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amdocs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.